213 related articles for article (PubMed ID: 27325333)
1. Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation-A Danish Nationwide Registry Study.
Jakobsen M; Kolodziejczyk C; Fredslund EK; Poulsen PB; Dybro L; Johnsen SP
Value Health; 2016 Jun; 19(4):413-8. PubMed ID: 27325333
[TBL] [Abstract][Full Text] [Related]
2. Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation - a nationwide cohort study.
Jakobsen M; Kolodziejczyk C; Klausen Fredslund E; Poulsen PB; Dybro L; Paaske Johnsen S
BMC Health Serv Res; 2017 Jun; 17(1):398. PubMed ID: 28606079
[TBL] [Abstract][Full Text] [Related]
3. Cost of illness of atrial fibrillation: a nationwide study of societal impact.
Johnsen SP; Dalby LW; Täckström T; Olsen J; Fraschke A
BMC Health Serv Res; 2017 Nov; 17(1):714. PubMed ID: 29126415
[TBL] [Abstract][Full Text] [Related]
4. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
[TBL] [Abstract][Full Text] [Related]
5. Acute hospital, community, and indirect costs of stroke associated with atrial fibrillation: population-based study.
Hannon N; Daly L; Murphy S; Smith S; Hayden D; Ní Chróinín D; Callaly E; Horgan G; Sheehan O; Honari B; Duggan J; Kyne L; Dolan E; Williams D; Wiley M; Kelly PJ
Stroke; 2014 Dec; 45(12):3670-4. PubMed ID: 25358697
[TBL] [Abstract][Full Text] [Related]
6. The cost savings of newer oral anticoagulants in atrial fibrillation-related stroke prevention
.
Masbah N; Macleod MJ
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):220-230. PubMed ID: 28025962
[TBL] [Abstract][Full Text] [Related]
7. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001.
Ghatnekar O; Glader EL
Value Health; 2008; 11(5):862-8. PubMed ID: 18489491
[TBL] [Abstract][Full Text] [Related]
8. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
Vestergaard AS; Skjøth F; Lip GY; Larsen TB
Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
[TBL] [Abstract][Full Text] [Related]
9. Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm.
Ali AN; Howe J; Abdel-Hafiz A
Pharmacoeconomics; 2015 May; 33(5):511-20. PubMed ID: 25693879
[TBL] [Abstract][Full Text] [Related]
10. Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study.
Yiin GS; Howard DP; Paul NL; Li L; Luengo-Fernandez R; Bull LM; Welch SJ; Gutnikov SA; Mehta Z; Rothwell PM;
Circulation; 2014 Oct; 130(15):1236-44. PubMed ID: 25208551
[TBL] [Abstract][Full Text] [Related]
11. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
[TBL] [Abstract][Full Text] [Related]
13. Using Phase-Based Costing of Real-World Data to Inform Decision-Analytic Models for Atrial Fibrillation.
Tawfik A; Wodchis WP; Pechlivanoglou P; Hoch J; Husereau D; Krahn M
Appl Health Econ Health Policy; 2016 Jun; 14(3):313-22. PubMed ID: 26924098
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
15. 30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
Schmidt M; Ulrichsen SP; Pedersen L; Bøtker HE; Nielsen JC; Sørensen HT
Int J Cardiol; 2016 Dec; 225():30-36. PubMed ID: 27705839
[TBL] [Abstract][Full Text] [Related]
16. Impact of atrial fibrillation on stroke-related healthcare costs.
Sussman M; Menzin J; Lin I; Kwong WJ; Munsell M; Friedman M; Selim M
J Am Heart Assoc; 2013 Nov; 2(6):e000479. PubMed ID: 24275631
[TBL] [Abstract][Full Text] [Related]
17. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.
Vadstrup K; Alulis S; Borsi A; Elkjaer Stallknecht S; Nielsen A; Rikke Jørgensen T; Wennerström C; Qvist N; Munkholm P
Scand J Gastroenterol; 2020 Jan; 55(1):41-46. PubMed ID: 31960726
[No Abstract] [Full Text] [Related]
18. Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients.
Nguyen E; Egri F; Mearns ES; White CM; Coleman CI
Pharmacotherapy; 2016 May; 36(5):488-95. PubMed ID: 27015873
[TBL] [Abstract][Full Text] [Related]
19. Atrial Fibrillation as an Ischemic Stroke Clinical and Economic Burden Modifier: A 15-Year Nationwide Study.
Santos JV; Pereira J; Pinto R; Castro PM; Azevedo E; Freitas A
Value Health; 2017 Sep; 20(8):1083-1091. PubMed ID: 28964440
[TBL] [Abstract][Full Text] [Related]
20. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study.
Brüggenjürgen B; Rossnagel K; Roll S; Andersson FL; Selim D; Müller-Nordhorn J; Nolte CH; Jungehülsing GJ; Villringer A; Willich SN
Value Health; 2007; 10(2):137-43. PubMed ID: 17391422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
